Summary of Results
| Result | ||||
|---|---|---|---|---|
| Stage | 123I-MIBG > 18F-FDG | 18F-FDG > 123I-MIBG | Equivalent | Negative |
| Stage 1 and 2 neuroblastoma (13 scans/10 patients*) | ||||
| Diagnosis | — | 4 scans/4 pts | 1 scan/1 pt | — |
| Follow-up | — | 5 scans/3 pts | — | 3 scans/3 pts |
| Total | — | 9 scans/6 pts | 1 scan/1 pt | 3 scans/3 pts |
| Stage 3 neuroblastoma (15 scans/10 patients*) | ||||
| Diagnosis | — | 1 scan/1 pt | 2 scans/2 pts | — |
| Follow-up | 5 scans/4 pts | 3 scans/3 pts | — | 4 scans/3 pts |
| Total | 5 scans/4 pts | 4 scans/4 pts | 2 scans/2 pts | 4 scans/3 pts |
| Stage 4 neuroblastoma (85 scans/40 patients*) | ||||
| Diagnosis | 8 scans/8 pts | 3 scans/3 pts | 5 scans/5 pts | — |
| Follow-up ≤ 12 months | 19 scans/12 pts | 5 scans/3 pts | 5 scans/5 pts | 6 scans/5 pts |
| Follow-up > 12 months | 17 scans/10 pts | 3 scans/3 pts | 3 scans/3 pts | 11 scans/10 pts |
| Total | 44 scans/24 pts | 11 scans/8 pts | 13 scans/11 pts | 17 scans/14 pts |
↵* Patients with more than 1 scan during study period may be listed in different categories (i.e., patients scanned at both diagnosis and follow-up or patients with multiple follow-up scans with different results).
123I-MIBG > 18F-FDG = numbers of scans and patients for which 123I-MIBG detected more lesions; pts = patients; 18F-FDG > 123I-MIBG = numbers of scans and patients for which 18F-FDG detected more lesions; Equivalent = numbers of scans and patients for which 123I-MIBG and 18F-FDG detected similar or complementary numbers and distributions of lesions; Negative = numbers of scans and patients for which 123I-MIBG and 18F-FDG study results were normal.